AMR: UK’s Subscription Scheme ‘One Way Forward,’ But New Economic Models Needed

Stimulating the development of novel antibiotic drugs and diagnostics will require new funding models as part of the broader “push and pull” incentives strategy, says the director of health & life sciences at Innovate UK.